These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4390341)

  • 1. Peripheral factors in the mediation of the effects of L-dopa on locomotor activity.
    Butcher LL; Engel J
    J Pharm Pharmacol; 1969 Sep; 21(9):614-6. PubMed ID: 4390341
    [No Abstract]   [Full Text] [Related]  

  • 2. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenously released L-dopa itself tonically functions to potentiate postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
    Yue JL; Nakamura S; Ueda H; Misu Y
    Neurosci Lett; 1994 Mar; 170(1):107-10. PubMed ID: 7913742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine, noradrenaline and 5-hydroxy-trytamine in relation to motor activity, fighting and mounting behaviour. II. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602 and parachlorophenylalanine.
    Benkert O; Renz A; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):187-93. PubMed ID: 4266876
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR; Baumeister A; Napier TC; Frye GD; Mueller RA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of DL- -methyltyrosine and L-DOPA on the hyperthermic and behavioral actions of LSD in rabbits.
    Horita A; Hamilton AE
    Neuropharmacology; 1973 May; 12(5):471-6. PubMed ID: 4708475
    [No Abstract]   [Full Text] [Related]  

  • 16. A scatter-jump syndrome with gnawing and fighting induced by L-dopa in mice.
    Bryson G; Bischoff F
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):469-76. PubMed ID: 5167776
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of amphetamine, L-DOPA and apomorphine on morphine-induced behavioural excitation of rats.
    Ayhan IH; Randrup A
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):283-92. PubMed ID: 4748782
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of L-DOPA on motor behavior in a rat with a unilateral striatal neoplasm.
    Griffith D; Narotzky R; McLone D
    Acta Neuropathol; 1972; 22(3):269-71. PubMed ID: 4344342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.